Apiam is please to announce that we have received approval from the APVMA to manufacture under permit a unique custom Histophilus somni vaccine for cattle, sheep and goats.
Since the acquisition of ACE Laboratories in December 2019, Apiam has now brought to market three new vaccines for the cattle industry, to improve the health of livestock and to enhance antimicrobial stewardship programs.
We have also introduced new technologies in the development of these vaccines, which will now be applied across our entire vaccine portfolio including our pigs and poultry vaccines. In a step change for industry, we expect that this will result in even higher vaccine efficacy delivering better animal health outcomes.
Being able to develop and manufacturer these technologies locally at our Bendigo facility is what makes custom vaccines so valuable to our domestic livestock industries, especially when we are seeing antigenic drift on Australian farms as well as lack of effectiveness of some imported commercial vaccines.
Read the media release below.
